Loomis Sayles & CO L P Novo Cure LTD Transaction History

Loomis Sayles & CO L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$130.4 - $225.58 $11,736 - $20,302	-90 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $868 - $1,331	-7 Reduced 7.22%	90 $12,000
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $10,879 - $16,891	97 New	97 $17,000
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $20.1 Million - $36.9 Million	-701,565 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$32.0 - $52.4 $2.57 Million - $4.21 Million	-80,289 Reduced 10.27%	701,565 $36.8 Million
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $203,601 - $328,224	10,257 Added 1.33%	781,854 $24.5 Million
Q1 2018 May 11, 2018	BUY	$19.3 - $23.65 $14.9 Million - $18.2 Million	771,597 New	771,597 $16.8 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.03B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.